Prevalence of celiac disease in Germany: A prospective follow-up study

Table 3 Change in celiac-specific antibody titers over time

No.	Age (yr), sex	Initial examination			First follow up
		tTG-IgA (U/mL)	AGA (U/mL)	EMA	tTG-IgA (U/mL)	AGA (U/mL)	EMA
Classic celiac disease
2	58, F	5.5	19.4	Weak Pos	Neg	Neg	Neg
4	20, F	> 100	27.6	Pos	Neg	Neg	Neg
5	52, F	44.9	24.7	Pos	Neg	Neg	Neg
17	56, M	Neg	78.1	Pos	Neg	Neg	Neg
18	62, F	Neg	Neg	Neg	7	> 100	Neg
Atypical celiac disease
1	40, M	> 100	69.6	Pos	29.9	38.1	Pos
3	42, F	41.9	56.2	Pos	27	20.1	Pos
Transient celiac disease
16	18, F	Neg	Neg	Neg	Neg	Neg	Neg

No.: Subject number; F: Female; M: Male; tTG-IgA: Tissue transglutaminase immunoglobulin A; AGA: Antigliadin antibody immunoglobulin A; EMA: Endomysial antibody; Pos: Positive; Neg: Negative.